Actions speak louder. I don't understand this bipartisan immigration reform. Kevin McCarthy was on the show the other day, and he said Joe Biden hasn't talked to him since he's been inaugurated that he's reached out to the president and he hasn't reached back is a week or two ago where McConnell said the Biden hadn't talked to him. Joe Biden is not interested in any of this Fine doesn't even talk to the Republican Mark Levin weekday afternoons of three on 5 60 KSFO or tell your Google device to play KSFO. It's time for your Fox News coming, Terry, Dr Nicole Sapphire. What's on your mind? Up until last week. Even prior, Big Pharma naysayers were touting the successful development of effective covert 19 vaccines within 15 months of a pandemic, not one, but three pharmaceutical companies developed and made available vaccines to leave the United States for immunity. Nirvana. Now over 250 million doses have been delivered in under five months rather than congratulating Big Pharma on their tremendous efforts during a time of peril. Last week, President Biden held true on a controversial campaign promise, doing the opposite. So loving increased scrutiny from progressive activists. The Biden administration announced its support of a plan reeks, sending intellectual property rights on covert 19 vaccines, saying The administration believes strongly in intellectual property protections. But in service of ending this pandemic supports the waiver of those protections for covert 19 vaccines. Intellectual property rights, as they relate to. Big Pharma often have a depraved reputation of solely trying to maximize profits, but they actually serve multiple important functions, including continued work on innovation and reducing lesser quality products from entering the market. Operation Works feed a public private collaboration generated billions at exactly the right moment playing a crucial role in vaccine availability. But the base of the effort depended on the slow, extraordinarily laborious process of scientific research over two decades, much of which was done at privately owned firms under the auspices of intellectual property rights. It was not government spending in of itself that saved us. The technology behind the vaccines was created over years of private investment on a global scale, as described by Peter Pitts, president and co founder of the Center for Medicine in Public Interest. The United States is the global leader in pharmaceutical development, largely in part due to robust intellectual property right laws and free market pricing. The waiver of property rights is a long sought political goal, but does more virtue signaling than provide immediate, tangible help for struggling nations. Without providing the personnel and other resource is necessary. It will do little to help struggling nations develop, manufacture and distribute the vaccines. Rather than strip private entities of their intellectual property rights. Wealthy governments can continue to donate unused vaccine doses and supplies, while pharmaceutical companies consider donating vaccines or selling them reduced prices as they customarily do. Maybe we need to rethink the inherently pejorative notions of big pharma itself. Perhaps it is not a malevolent engine of profit making, but a collection of diverse It's entities and actors and maybe profit making and protection of intellectual property rights properly understood, play a crucial role, though not a solitary role in driving innovation. While it is unlikely anything immediate will come from the World Trade Organization discussions, ignoring protection waivers can set a dangerous precedent. Once we start chipping away at intellectual property rights, there is no turning back on the slippery slope. I'm Dr Nicole Sapphire, assistant professor at Memorial Sloan Kettering Cancer Center. And while Cornell Medical.